Of course, the impact of purine inhibitors such as AGF94 may have a broader impact, via effects on adenosine pools in the tumor microenvironment from tumor cells which act as an immune modulator resulting in macrophage polarization45 and inhibition of cytotoxic effector functions of NK and CD8+ T cells46–48. The gene discussed is CD8A; the disease is neoplasm.